Immatics (IMTX)

• Market cap: $1.27B
• 1 day: 0.77%
• 5 days: 1.26%
• 1 month: 22.3%
• 3 months: 55.99%
• 6 months: 108.4%
• Year to date: 40.43%
• 1 year: 12.89%
• 5 years: 0.39%
• 10 years: 8.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 423